• Home
  • /
  • Topic
  • /
  • Health
  • /
  • Lupus
  • /
  • Oral Lupus Etiology Epidemiology and Clinical Decisions Research Paper
Verified Document

Oral Lupus: Etiology, Epidemiology, And Clinical Decisions Research Paper

Oral Manifestations of Lupus Erythematosus Oral Manifestations of Lupus

Oral Manifestations of Lupus Erythematosis

Systemic lupus erythematosus (SLE), or lupus for short, is a chronic and generally progressive autoimmune disease affecting many tissues in the body (Lupus Foundation of America, 2015). The U.S. Centers for Disease Control and Prevention (CDC, 2015) discriminates between SLE and lupus affecting the skin only (discoid/cutaneous lupus erythematosis) or that caused by medications (temporary). SLE and cutaneous lupus erythematosus (CLE) are the only two types of lupus relevant to this article, since temporary lupus can be treated effectively by changing medication. Prevalence estimates vary considerably, but in the United States an estimated 161,000 individuals have a definitive diagnosis of SLE. Information about incidence rates is equally poor, but the most recent study found that 5.6 out of 100,000 Whites in Rochester, Minnesota developed SLE between 1980 and 1992. What follows is a detailed examination of lupus erythematosus (LE), oral manifestations of this disease, and a discussion of the recommended treatment approaches.

BRIEF 1:

Lupus is caused by a person's immune system malfunctioning and the generation and expansion of auto-antibodies recognizing healthy tissue (Lupus Foundation of America, 2015). The targeted tissues in turn suffer from chronic and often progressively painful inflammation and localized tissue damage. Although the disease can manifest at any point in person's lifespan, minority women between the ages of 15 and 40 represent the demographic with the highest incidence rates (CDC, 2015). The cause of the disease is unknown, but infections or other environmental factors may trigger disease onset in genetically susceptible individuals (Mayo Clinic Staff, 2014a). Only a small number individuals, however, who have a family history of autoimmune disease will develop LE, so it is hard to predict which family members will develop the disease. The signs and symptoms associated with SLE include arthritis, skin rashes, photosensitivity, pleuritis, pericarditis, blood cell abnormalities, kidney problems, seizures, and psychosis, but most relevant to this discussion is the manifestation of oral ulcers. The primary treatment approaches rely on the administration of immunosuppressants, which are effective is slowing disease progression and minimizing flares. Flares can be life-threatening and hospitalizations...

In the absence of a diagnosis and effective treatment, the risk of serious complications and even death is significant.
BRIEF 2:

The oral manifestations of SLE include discoid lesions, honeycomb plaques, raised keratotic plaques (horny growth similar to warts), erythema (capillary dilation), purpura (small hemorrhage), petechiae (sub-epidermal hemorrhage), cheilitis (inflammation and cracking of lips), and ulcers with an irregular shape (Chi, Neville, Krayer, & Gonsalves, 2010). Lesions will develop in patients suffering from CLE, but only in the presence of skin lesions. Researchers examined the oral lesions of 46 patients with a confirmed diagnosis of SLE or CLE and found the most common oral lesion to be lichenoid mucositis (Lourenco et al., 2007). The lichenoid mucositis lesions were associated with a perivascular inflammatory infiltrate and localized epithelial thickenings or atrophy. Spongiosis, to varying degrees, was also observed in most patients. Histological examination of biopsy samples revealed IgG, IgM, and/or C3 (complement factor 3) deposits in the basement membrane in all samples and immune infiltrates consisting primarily of CD4+ T cells. CD20+ B cells and macrophages were also present, but in far fewer numbers compared to T cells. Importantly, oral lesions were most common in adult women suffering from CLE (73.9%), rather than SLE (26.1%); although, the reverse has been found by other researchers sampling different populations (e.g., see Chi et al., 2010). Most patients in the study were women and the median age of those with oral lesions was 41.8 years.

BRIEF 3:

Diagnosis of SLE or CLE (LE) with oral manifestations, in the absence of a formal diagnosis of LE, can be obtained through histopathology and direct immune-fluorescence (DIF) of oral biopsy samples (Lourenco et al., 2007). The most common histopathological findings will be ". . . epithelial hyperkeratosis with atrophy of the rete pegs, superficial and deep mononuclear inflammatory infiltrate, edema in the lamina propria, liquefative degeneration of basal epithelial cells and predominantly patchy PAS-positive subepithelial deposits" (p. 561). DIF results will reveal primarily IgM deposits in the basement membrane and perivascular T cell infiltrates. A differential diagnosis against several other conditions must be performed to rule out other causes of the oral lesions.

Once a diagnosis of…

Sources used in this document:
References

Brennan, M.T., Valerin, M.A., Napenas, J.J., & Lockhart, P.B. (2005). Oral manifestations of patients with lupus erythematosus. Dental Clinics of North America, 49(1), 127-41.

Chi, A.C., Neville, B.W., Krayer, J.W., & Gonsalves, W.C. (2010). Oral manifestations of systemic disease. American Family Physician, 82(11), 1381-8.

Lourenco, S.V., de Carvalho, F.R., Boggio, P., Sotto, M.N., Vilela, M.A., Rivitti, E.A. et al. (2007). Lupus erythematosus: Clinical and histopathological study of oral manifestations and immunohistochemical profile of the inflammatory infiltrate. Journal of Cutaneous Pathology, 34(7), 558-64.

Lupus Foundation of America. (2015). Get Answers: Understanding Lupus: What is Lupus?. Retrieved from http://www.lupus.org/answers/entry/what-is-lupus.
Mayo Clinic Staff. (2014a). Lupus: Causes. Retrieved from http://www.mayoclinic.org/diseases-conditions/lupus/basics/causes/con-20019676.
Mayo Clinic Staff. (2014b). Lupus: Preparing for your appointment. Retrieved from http://www.mayoclinic.org/diseases-conditions/lupus/basics/preparing-for-your-appointment/con-20019676.
U.S. Centers for Disease Control and Prevention. (2015). Arthritis: Systemic lupus erythematosis (SLE or lupus). Retrieved from http://www.cdc.gov/arthritis/basics/lupus.htm.
Cite this Document:
Copy Bibliography Citation

Related Documents

Lupus - Systemic Lupus Erythematosus
Words: 2310 Length: 8 Document Type: Thesis

CellCept drug for the treatment of kidney complications could be a boon to lupus patients (Chang, 2005). A small study showed that the drug delivered better results than standard chemotherapy, which could cause infertility and other medical problems. A recent experiment compared the effects of CellCept and the older treatment, cyclophosphamide, in patients for 6 months. Those taking CellCept reported fewer side effects. The researchers were led by Dr. Ellen

Lupus Refers to a Group
Words: 1221 Length: 4 Document Type: Term Paper

The most common cause of death is infection due to immunosuppression, a result in turn of medications intended to manage the disease. Chances are worse for men and children than for women. After the age of 60, the disease tends to turn benign. The only marker of prognosis in lupus is the anti-ds DNA antibody test and the most sensitive is the Anti-Smith test (Wikipedia) The standard treatment for lupus

Systemic Lupus Case Study
Words: 738 Length: 2 Document Type: Case Study

Systemic Lupus Erythematosus Case Study Systemic Lupus Erythematosus Systemic lupus erythematosus (SLE) is a chronic, life-long autoimmune disease that affects multiple tissues and organs in the body (Madhok and Wu, 2009). The primary tissues and organs affected by immune system dysfunction are the joints, kidneys, vessel walls, and skin. SLE is believed to be due to an interaction between genetic factors and environmental triggers. The disease is also more prevalent among women,

Systemic Lupus Erythematosus Sle or
Words: 844 Length: 3 Document Type: Term Paper

Anti-Smith antigen is observed in 25% of patients with SLE overall, with 10-20% whites and 30-40% blacks and Asians and Lupus erythematosus (LE) preparation is found in most patients with active SLE. Treating the active phase of the disease without allowing the treatment itself to cause long-term damage to the patient is the major challenge for doctors. As a result of this physicians are now less hesitant to use immunosuppressive

Oral Hygiene Needs of the
Words: 1221 Length: 4 Document Type: Thesis

Another caution that exists for people suffering from lupus is to exercise caution before and after receiving dental treatment. Lupus patients could develop serious heart infections from the streptococci that might be released into their bloodstream during routine dental procedures, even bi-annual teeth cleanings (Blau and Schultz, 174). The infection can travel to the heart when the patient has certain other manifestations of lupus, and, if the patient has developed

Autoimmune Disorders Maladaptive Responses to
Words: 690 Length: 2 Document Type: Essay

"Inflammatory Bowel Diseases (IBD) is a broad term that describes conditions with chronic or recurring immune response and inflammation of the gastrointestinal tract. The two most common inflammatory bowel diseases are ulcerative colitis and Crohn's disease" (IBD, 2013, CDC). Ulcerative colitis affects the large colon; Crohn's usually affects the small colon and the beginning portion of the large colon. Regardless in both manifestations of IBD, the body attacks the

Sign Up for Unlimited Study Help

Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.

Get Started Now